Market revenue in 2021 | USD 2,504.4 million |
Market revenue in 2027 | USD 2,155.6 million |
Growth rate | -2.5% (CAGR from 2021 to 2027) |
Largest segment | Prefilled syringe |
Fastest growing segment | Inhalers |
Historical data covered | 2016 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2027 |
Quantitative units | Revenue in USD million |
Market segmentation | Prefilled syringe, Inhalers |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to covid-19 drug delivery devices market will help companies and investors design strategic landscapes.
prefilled syringe was the largest segment with a revenue share of 64.81% in 2021. Horizon Databook has segmented the Global covid-19 drug delivery devices market based on prefilled syringe, inhalers covering the revenue growth of each sub-segment from 2016 to 2027.
Horizon Databook provides a detailed overview of global-level data and insights on the Global covid-19 drug delivery devices market, including forecasts for subscribers. This global databook contains high-level insights into Global covid-19 drug delivery devices market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account